NCT02763215View on ClinicalTrials.gov

The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

May 19, 2016

Primary Completion Date

January 21, 2019

Study Completion Date

January 21, 2019

Conditions
Wilson Disease
Interventions
DRUG

Standard of Care Medications

Standard of care medications could include penicillamine, trientine, zinc, or a combination of a copper chelator and zinc.

Trial Locations (10)

1090

Clinical Trial Site, Vienna

37240

Clinical Trial Site, Nashville

48109

Clinical Trial Site, Ann Arbor

60611

Clinical Trial Site, Chicago

69120

Clinical Trial Site, Heidelberg

98105

Clinical Trial Site, Seattle

06504

Clinical Trial Site, New Haven

02-957

Clinical Trial Site, Warsaw

B15 2GW

Clinical Trial Site, Birmingham

GU2 7XX

Clinical Trial Site, Guildford

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY